As shown in Fig. 2C, MTT assay was used to observe the effect of HER-4 on osteosarcoma cells proliferation.Compared with sh-con groups, sh-HER4 markedly decreased U2OS and MG-63 cell viability (P<0.05). Here, ERBB4 is linked to osteosarcoma.